|

Pioglitazone Clinical Trials

10 actively recruiting trials across 3 locations

Also known as: Actos, Actos Tab., PIO, actos

Pipeline

Early 1: 1Phase 2: 2Phase 3: 2Phase 4: 3Phase 1/2: 1

Top Sponsors

  • The University of Texas Health Science Center at San Antonio4
  • University of Florida1
  • Seoul National University Bundang Hospital1
  • Rambam Health Care Campus1
  • National Institute of Allergy and Infectious Diseases (NIAID)1

Indications

  • Diabetes7
  • Liver Disease2
  • Type 2 Diabetes2
  • Cancer2
  • Type 2 Diabetes (Adult Onset)1

Other4 trials

A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
Phase 2
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
Early 1
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Phase 3
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Phase 4

San Antonio, Texas4 trials

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

University Health System Texas Diabetic Institute

Phase 3
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Texas Diabetes Institute/UH

Phase 4
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio

N/A
Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System

Phase 4

Gainesville, Florida1 trial

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

University of Florida

Phase 2

Bethesda, Maryland1 trial

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.